Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Rapezzi

Showing results (101-110 of 404) with videos related to

Pageof 41
Sort By:
European Journal of Heart Failure|August 19, 2003
Cardioverter-defibrillators after MADIT-II: the balance between weight of evidence and treatment costsGiuseppe Boriani, Mauro Biffi, Cristian Martignani, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Antithrombotic Management during Percutaneous Mitral Valve Repair with the Mitraclip System in a Patient with Heparin-Induced ThrombocytopeniaFrancesco Saia, Elena Biagini, Alessandra Berardini, et al.
Drugs|August 22, 2019
Sacubitril/Valsartan: Updates and Clinical Evidence for a Disease-Modifying ApproachEnrico Fabris, Marco Merlo, Claudio Rapezzi, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|March 25, 2015
Brain Microbleeds 12 Years after Orthotopic Liver Transplantation in Val30Met AmyloidosisFabrizio Salvi, Francesca Pastorelli, Rosaria Plasmati, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 21, 2018
State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosisVasvi Singh, Rodney Falk, Marcelo F Di Carli, et al.
European Journal of Preventive Cardiology|August 17, 2021
Management of complications of cardiac amyloidosis: 10 questions and answersAlberto Aimo, Claudio Rapezzi, Giuseppe Vergaro, et al.
Minerva Cardiology and Angiology|April 12, 2022
The revolution of ATTR amyloidosis in cardiology: certainties, gray zones and perspectivesClaudio Rapezzi, Giuseppe Vergaro, Michele Emdin, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 25, 2019
Assessment of patients with hereditary transthyretin amyloidosis - understanding the impact of management and disease progressionIsabel Conceição, Teresa Coelho, Claudio Rapezzi, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|May 22, 2018
Failure of Tafamidis to Halt Progression of Ala36Pro TTR Oculomeningovascular AmyloidosisFabrizio Salvi, Roberto Volpe, Francesca Pastorelli, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|June 12, 2020
A new therapy for transthyretin amyloidosis, no longer an orphan conditionCandida Cristina Quarta, Anna Laura Tinuper, Agnese Milandri, et al.
Pageof 41

Showing results (101-110 of 404) with videos related to

Sort By:
Pageof 41
European Journal of Heart Failure|August 19, 2003
Cardioverter-defibrillators after MADIT-II: the balance between weight of evidence and treatment costsGiuseppe Boriani, Mauro Biffi, Cristian Martignani, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Antithrombotic Management during Percutaneous Mitral Valve Repair with the Mitraclip System in a Patient with Heparin-Induced ThrombocytopeniaFrancesco Saia, Elena Biagini, Alessandra Berardini, et al.
Drugs|August 22, 2019
Sacubitril/Valsartan: Updates and Clinical Evidence for a Disease-Modifying ApproachEnrico Fabris, Marco Merlo, Claudio Rapezzi, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|March 25, 2015
Brain Microbleeds 12 Years after Orthotopic Liver Transplantation in Val30Met AmyloidosisFabrizio Salvi, Francesca Pastorelli, Rosaria Plasmati, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 21, 2018
State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosisVasvi Singh, Rodney Falk, Marcelo F Di Carli, et al.
European Journal of Preventive Cardiology|August 17, 2021
Management of complications of cardiac amyloidosis: 10 questions and answersAlberto Aimo, Claudio Rapezzi, Giuseppe Vergaro, et al.
Minerva Cardiology and Angiology|April 12, 2022
The revolution of ATTR amyloidosis in cardiology: certainties, gray zones and perspectivesClaudio Rapezzi, Giuseppe Vergaro, Michele Emdin, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 25, 2019
Assessment of patients with hereditary transthyretin amyloidosis - understanding the impact of management and disease progressionIsabel Conceição, Teresa Coelho, Claudio Rapezzi, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|May 22, 2018
Failure of Tafamidis to Halt Progression of Ala36Pro TTR Oculomeningovascular AmyloidosisFabrizio Salvi, Roberto Volpe, Francesca Pastorelli, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|June 12, 2020
A new therapy for transthyretin amyloidosis, no longer an orphan conditionCandida Cristina Quarta, Anna Laura Tinuper, Agnese Milandri, et al.
Pageof 41